Professor talking through a powerpoint presentation projected on to a screen

Part-Time MBA concentration in Pharmaceutical Management

Want to build a successful career in the pharmaceutical and biotech industries? You've come to the right place.

Why biopharma companies recruit Rutgers MBA students

Rutgers Business School is ranked among the top 5 B-schools for healthcare, pharma and biotech worldwide and is a hub for pharmaceutical knowledge and connections.

Our students are driven. Our alumni are successful. Our faculty are in-the-know.

All that's missing is you.

Connected to Industry

More than half of the 20 largest pharma companies worldwide – companies like Novartis, Johnson & Johnson, Bristol-Myers Squibb, Merck, Novo Nordisk and Bayer Healthcare – call New Jersey home. So do a network of teaching hospitals and medical schools here and in neighboring New York City. If access to Big Pharma and healthcare is what you are looking for, Rutgers Business School is uniquely positioned to deliver.

Over the years, we've developed a legacy of strong relationships within this space that inform curriculum, enhance the student experience and connect students to jobs.

Curriculum

Our Pharmaceutical Management MBA curriculum is in sync with the rhythm of the industry, which means you'll enter the workforce with readily applicable knowledge taught to you by distinguished academics and former executives. The Pharma MBA experience is the best of theory and practice.

Our curriculum is expansive and addresses a variety of issues affecting the industry today.

Sample Courses
  • Ethics in the Pharmaceutical Industry
  • Managing the Pharmaceutical Sales Organization
  • Pharmaceutical Industry: Issues, Structure & Dynamics
  • Pharmaceutical Marketing Research
  • Pharmaceutical Product Management
  • U.S. Healthcare System & Pharmaceutical Managed Markets
Members of the Rutgers Biopharmaceutical Case Competition team pose in front of the competition banner

The Lerner Center

The Pharmaceutical Management concentration is strengthened by the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues and the center’s ties to major healthcare companies. Founded in 2004, The Lerner Center encourages research and thought leadership on critical economic, regulatory and strategic industry issues. Its ultimate goal is to position Rutgers Business School as an epicenter of excellence in research and training in healthcare management studies.

To achieve that, the Lerner Center’s mission is:

  • To facilitate an exchange of management and research ideas among biopharmaceutical industry professionals and academia through seminars, symposia, workshops and collaborative research projects.
  • To support faculty and doctoral students in their research and teaching of economic, managerial and strategic issues confronting the biopharmaceutical industry.
  • To provide executive education programs that will help to develop the next generation of industry leaders.

Board of Advisors

The Rutgers MBA in Pharmaceutical Management was designed with substantial industry input. Members of the Board of Advisors work to ensure that the curriculum remains relevant by providing ongoing advice and guidance. They also interview every candidate for an industry scholarship, play a key role in organizing monthly industry seminars, and serve as valuable ambassadors for their companies. 

Program Sponsors

Bayer
Bristol-Myers Squibb Company
Johnson and Johnson
Novartis
I've experienced the training first-hand and I see it in all of the students I recruit each and every year. It's the industry involvement ... the alums coming back and speaking, as well as the coursework and the framework for the pharma industry that really prepares the students. They've learned the skills at Rutgers Business School that they can now apply at work each and every day and it propels them, not just to be great marketers, to be great supply chain experts, but to be great leaders ...
—  Gregg Ruppersberger, MBA, Group Product Director, Janssen Pharmaceuticals, Inc.